ClinicalTrials.gg
CompletedNCT07884162Updated Nov 10, 2026

Plyometric vs. Intrinsic Foot Muscle Training in Pediatric Flatfoot

An interventional study of Plyometric Training in Flatfoot, Flexible, sponsored by Faculty of Medicine, Sousse. Completed at 1 site in Tunisia. Open to male participants aged 9 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Faculty of Medicine, Sousse · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Nov 2025, registered Oct 2026).
Updated Nov 10, 2026Primary completion movedStudy completion moved+1 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
9 Years to 12 Years
Sex
Male
01

Study summary

The purpose of this study is to investigate how the order of exercises in a training program affects foot mechanics and physical performance in children with flexible flatfoot. Flexible flatfoot is common in children and can affect how weight is distributed on the foot, balance, and athletic abilities. While both foot-strengthening exercises and jump training (plyometrics) are helpful, it is not known which one should be done first to get the best results.

In this study, thirty-six young male football players with flexible flatfoot were divided into three groups. The first group performed jump training followed by foot muscle strengthening. The second group did the foot muscle strengthening first, followed by jump training. The third group served as a control group and did not change their usual training. The researchers measured changes in foot pressure, balance, jumping height, muscle force, and sprint speed before and after the training to find out which exercise order is most effective for improving athletic performance and foot loading.

Read the detailed description

This study evaluates the impact of exercise sequencing within a combined training program for young athletes with flexible flatfoot. Participants are block-randomized into three distinct parallel arms to compare different training structures over the intervention period:

  • Group P1-R2: Participants undergo plyometric training in the first phase, followed by intrinsic foot muscle (IFM) strengthening in the second phase.
  • Group R1-P2: Participants undergo intrinsic foot muscle (IFM) strengthening in the first phase, followed by plyometric training in the second phase.
  • Control Group (CG): Participants maintain their habitual football training schedule without any additional specific foot or plyometric interventions.

All participants undergo a comprehensive testing battery at baseline (pre-intervention) and immediately following the completion of the training protocol (post-intervention). The assessments include static and dynamic baropodometric analyses to measure peak plantar pressure, postural tracking to evaluate balance, countermovement jump (CMJ) tests for neuromuscular mechanics, eccentric rate of force development (RFD) evaluations, and 20-meter timed sprints to quantify locomotor performance.

02

Conditions studied

  • Flatfoot, Flexible

Browse trials for

Keywords

  • Intrinsic foot muscles
  • postural stability
03

In context

Flatfoot

173 studies on the registry are indexed under Flatfoot; 44 are open to participants now.

This study's enrollment of 36 is close to the median of 40 across 122 interventional studies indexed under Flatfoot.

Browse Flatfoot studies →

Lead sponsor

Faculty of Medicine, Sousse is the lead sponsor of 23 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
9 Years to 12 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants were required to be actively practising youth football players aged between 9 and 12 years with a clinically and podographically confirmed diagnosis of bilateral flexible flatfoot according to the study's predefined diagnostic criteria.

Exclusion criteria

Exclusion Criteria:

  • Participants were excluded if they presented any history of lower limb orthopaedic surgery, a musculoskeletal injury within the preceding six months, or a diagnosed neurological disorder.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
Single (Outcomes assessor)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    Group P1-R2

    Pediatric football players with flexible flatfoot who undergo a combined training program consisting of 4 weeks of plyometric training (Phase 1) followed by 4 weeks of intrinsic foot muscle strengthening (Phase 2), performed 3 times per week for a total of 8 weeks.

    Behavioral: Plyometric Training

  • Experimental
    Group R1-P2

    A separate group of pediatric football players with flexible flatfoot who undergo the inverse sequence: 4 weeks of intrinsic foot muscle strengthening (Phase 1) followed by 4 weeks of plyometric training (Phase 2), performed 3 times per week for a total of 8 weeks.

    Behavioral: Plyometric Training

  • No intervention
    Control Group

    A third separate group of pediatric football players with flexible flatfoot who maintain their habitual football training schedule without participating in any specific plyometric or foot muscle strengthening protocols during the 8-week study period.

Interventions

  • BehavioralPlyometric Training

    Jump and plyometric exercises performed 3 times per week for a total duration of 4 weeks. This intervention is implemented during Phase 1 for Group P1-R2 and during Phase 2 for Group R1-P2.

06

What researchers measure

Primary outcomes

  1. Peak Plantar Pressure

    Static and dynamic peak plantar pressure assessed using baropodometric analysis to evaluate changes in plantar loading.

    Time frame: Baseline (before the intervention) and post-intervention (after 8 weeks of training).

Secondary outcomes

  1. Postural Balance Tracking

    Postural stability tracking parameters evaluated under static and dynamic conditions.

    Time frame: Baseline (before the intervention) and post-intervention (after 8 weeks of training).

Other outcomes

  1. Countermovement Jump (CMJ) Height

    Vertical jump performance measured in centimeters using countermovement jump mechanics.

    Time frame: Baseline (before the intervention) and post-intervention (after 8 weeks of training).

  2. Eccentric Rate of Force Development (RFD)

    Neuromuscular force production capacity during the eccentric phase of movement.

    Time frame: Baseline (before the intervention) and post-intervention (after 8 weeks of training).

  3. 20-Meter Sprint Time

    Locomotor and acceleration performance measured in seconds.

    Time frame: Baseline (before the intervention) and post-intervention (after 8 weeks of training).

07

Study locations

1 site
  • Research Laboratory (LR19ES09), Exercise Physiology and Pathophysiology, Faculty of Medicine of Sousse, University of Sousse
    Sousse, 4002, Tunisia
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared outside of the research team to maintain participant confidentiality, as explicit consent for public data repository sharing was not obtained from the legal guardians at the time of enrollment.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2025 to primary completion in Mar 2026, 4 months.

Of 89 non-industry interventional studies with no phase under Flatfoot, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 15. This study's 4 months is below that.

Counting every sponsor, half of 89 studies reached it within 7 months; a quarter within 2 and three quarters within 15.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 10, 2026: primary completion Jan 2026 → Mar 2026 and completion May 2026 → Apr 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Oct 13, 2026
First posted
Oct 20, 2026
StartActual
Nov 15, 2025
Primary completionActual
Mar 30, 2026was Jan 2026
CompletionActual
Apr 15, 2026was May 2026
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jan 26, 2026→Mar 30, 2026
Nov 10, 2026
Study completion
May 15, 2026→Apr 15, 2026
Nov 10, 2026
Registered
First appeared on the registry
Oct 20, 2026
Show all 2 updates
  1. Nov 10, 2026
    Primary completion Jan 26, 2026→Mar 30, 2026
    Study completion May 15, 2026→Apr 15, 2026
    + 2 other changes: verification date and conditions
  2. Oct 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07884162
Lead sponsor
Faculty of Medicine, Sousse
Responsible party
Mounir Landolsi (Assistant Professor, Faculty of Medicine, Sousse) — Principal investigator
First posted
Oct 20, 2026
Start date
Nov 15, 2025
Primary completion
Mar 30, 2026
Completion
Apr 15, 2026
Last update
Nov 10, 2026

Study contacts

Mounir Landolsi, PhD
principal investigator · Faculty of Medecice of Sousse, University of Sousse

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion